Kalbe Farma Tbk vs Saraswanti Indoland Development Tbk. — how do they compare? Kalbe Farma Tbk trades at Rp720 (market cap 33T, 98.44M 24h volume), while Saraswanti Indoland Development Tbk. trades at Rp91 (market cap 500.81B, 1.26M 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 65.9× Saraswanti Indoland Development Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (98.44M versus 1.26M). Which is the better fit depends on your goals.
| KLBF | SWID | |
|---|---|---|
Market Cap | 33T | 500.81B |
Volume | 98.44M | 1.26M |
Lot | 984.38K | 12.61K |
Turnover | 70.64B | 113.99M |
Average Price | 717.58 | 90.38 |
Value | 70.64B | 113.99M |
Indicative Equilibrium Price | 720 | 91 |
Indicative Equilibrium Volume | 43.62K | 643 |
Trailing returns across standard periods
Latest headlines on both assets
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →PT Saraswanti Indoland Development Tbk ( The Company) was established on August 2, 2010 based on the Deed of Notary Ismaryani, SH, MKn. Number : 01. The deed of establishment of the Company was approved by the Minister of Law and Human Rights of the Republic of Indonesia number: AHU41610.AH.01.01.Tahun 2010. The Company started its commercial operations in 2011.
Read more on SWID →